주관중

진료분야

비뇨기계암(신장암,전립선암),비뇨기계암 수술 및 로봇수술, 혈뇨

진료일정

  • 외래진료
  • 국내 학회
  • 국외 학회
  • 강의
  • 휴가
  • 기타
구분 월 화 수 목 금 토
오전
오후
온라인 진료예약 바로가기

학력 및 경력

1986-1992 고려대학교 의과대학 졸업
1993-1997 고려대학교 의료원 비뇨기과 전공의 수료
1994-2002 고려대학교 대학원 의학 석사, 박사 취득
1997-2000 국군강릉병원 비뇨기과장
2000-2001 건양대학교 의과대학 부속병원 비뇨기과장
2006-2007 미국 Baylor College of Medicine. 비뇨기과 research fellowship.
2001-현재 성균관대학교 의과대학 강북삼성병원 비뇨기과 교수

학회 활동

[학회활동]
1997-현재 대한비뇨의학회 정회원 
2000~현재 대한남성과학회 정회원 
2002-현재 대한비뇨기종양학회 정회원 
2005~현재 대한비뇨내시경로봇학회 정회원 
2005~현재 대한전립선학회 정회원
2008~현재 대한배뇨장애요실금학회 정회원 
2008~현재 American Urological Association, International Member 
2010~현재 European Association of Urology, International Member  
2012~현재 대한임상보험의학회 법제이사  
2012~2016 International Continence Society, Member
2012~현재 보건복지부 신의료기술평가위원회 위원 
2014~현재 의료기관평가인증원 자원조사위원 
2015~현재 건강보험심사평가원 진료심사평가위원회 비상근심사위원
2017~현재 보건복지부 건강보험 전문평가위원
2017~현재 건강보험심사평가원 약제급여평가위원
2017~현재 한국의약품안전관리원 위원
2018~현재 건강보험분쟁조정위원회 의료자문단 자문의원
2018~현재 대한비뇨기종양학회 보험정책 부회장
2020~현재 건강보험심사평가원 암질환심의위원회 위원
2020~현재 대한비뇨의학회 보험이사

[집필서적]
2010 요로상피암 진료지침 (병인 부분 집필)/ 비뇨기종양학회 편저 /도서출판 의학문화사
2012 전립선암치료 길라잡이 (호르몬치료 부분 감수) / 대한전립선학회 /주식회사 메드랑



대표 논문

[국내]
(1) 문홍철, 주관중 , 박흥재. 돼지 방광의 점막하 조직과 무세포기질에서의 성장인자수용체와 신경영양성인자의 발현. 대한비뇨기과학회지. 2005;46권12호:1344-7.
(2) 안흥석, 권칠훈, 주관중. 혈청 PSA가 증가된 환자에서 생검부위 및 생검수에 따른 전립선암 진단율 비교. 대한비뇨기과학회지. 2006;47권 6호:591-5.
(3) 김홍국, 송인호, 변영민, 박흥재, 주관중, 김형지. 향후 치료를 위한 Chronic Prostatitis/Chronic Pelvic Pain syndrome 환자들의 증상분석. 대한배뇨장애 및 요실금 학회지. 2006;10권 1호:49-54.
(4) 이상욱, 홍성규, 변석수, 주관중, 이상은. 경직장초음파검사에서 국소병변이 보이는 환자에서 표준 6부위 생검과병변유도 생검 병용법의 진단적 가치에 대한 분석. 대한비뇨기과학회지. 2006;47권 7호:47-51.
(5) 김미진, 신건희, 류석태, 고성민, 김희진, 송상훈, 성수정, 주관중, 김수웅, 백재승, 손환철. 한국 젊은 남성의 발기부전 유병률과 위험요인에 대한 인터넷 조사 연구. 대한남성과학회지. 2006;24권 2호:76-83.
(6) 주관중, 박흥재, 김계환. 흰쥐의 뇌실주위신경핵에서 Oxytocin 발현에 미치는 유형 5 Phosphodiesterase 억제제(Vardenafil)의 영향에 대한 기초연구. 대한남성과학회지. 2006;24권 2호:94-7.
(7) 박종규, 박흥재, 주관중. 신우신염 백서모델에서 신염증 억제에 대한 젖소 초유와 항생제 병용 투여의 효과. 대한비뇨기과학회지. 2006;47권 10호:1111-6.
(8) 함영일, 주관중, 박흥재. 한국 성인남성에서 인체측정학적 인자 및 대사증후군 혈청학적 인자가 전립선특이항원에 미치는 영향. 대한비뇨기과학회지. 2009;50(7). 663-8.
(9) 박경서, 조영삼, 주관중. 배뇨근수축력저하가 동반된 전립선비대증 환자에서 KTP 레이저 전립선기화술이 배뇨근수축력에 미치는 영향. 대한비뇨기과학회지. 2009; 50(12). 1193-7.
(10) Cho YS, Joo KJ. Association of Prostate Specific Antigen (PSA) Velocity with Age and Initial PSA in Healthy Korean. 대한남성과학회지. 2010:28(1):16-21.
(11) 윤상진, 박호기, 정한, 주관중, 김계환. 음경골절의 가장 좋은 치료법은? 34명의 보존적 치료와 수술적 치료 경험의 비교. 대한남성과학회지. 2010:28(1):22-7.
(12) 고일규, 김성은, 김동현, 김태운, 김보균, 신말순, 김창주, 나용길, 주관중, 김계환. Tadalafil이 뇌 허혈 유발 모래 쥐의 운동 피질에서 세포 사멸에 미치는 영향. 대한남성과학회지. 2010:28(1). 47-56.
(13) Joon Chul Kim, Kwan Joong Joo, Jin Tae Kim, Jong Bo Choi, Dae Sung Cho, Yong Yeon Won. Alteration of autonomic function in female urinary incontinence. International Neurourological Journal 2010;14:232-37.
(14) Kwan Joong Joo. Role of clusterin and tumor necrosis factor receptors on the apoptosis of prostate cancer cells. Korean J Andrology. 2011;29(1):43-52.
(15) 주관중, 권칠훈. 재생검을 통해 전립선암으로 진단받은 환자의 임상적 예측요인. 대한남성과학회지. 2011;29(1):62-8.
(16) Sung Jin Yim, Young Sam Cho, Kwan Joong Joo. Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age. Korean J Urol. 2011;52(6):390-5.
(17) Ji Yong Lee, Kwan Joong Joo, Jin Tae Kim, Sung Tae Cho, Dae Sung Cho, Yong Yeun Won, Jong Bo Choi. Heart rate variability in men with erectile dysfunction. Int Neurourol J 2011;15:87-91.
(18) Kwan Joong Joo, Kwang chon Ko. Anticancer effects of conditionally replicating oncolytic herpes simplex virus against human bladder cancer cell lines. Korean J Urol Oncol 2011;9(2):55-61.
(19) Lee JS, Bae MH, Choi SH, Lee SH, Cho YS, Park HJ, Kwon CH, Joo KJ. Tumor establishment features of orthotopic murine bladder cancer models. Korean J Urol. 2012;53:396-400.

[국외]
(1) Kim SS, Park HJ, Han JH, Park MS, Park MY, Song KW, Joo KJ, Choi CY, Kim BS. Renal precusor cell transplantation using biodegradable polymer scaffolds. J Microbiol Biotechnol. 2005;15(1):105-11.
(2) Kim KH, Joo KJ, Park HJ, Kwon CH, Jang MH, Kim CJ. Nicotine induces apoptosis in TM3 mouse Leydig cells. Fertil Steril. 2005;83 Suppl 1:1093-9.
(3) Lhee HY, Kim H, Joo KJ, Jung SS, Lee KB. The clinical significance of serum and urinary neopterin levels in several renal diseases. J. Korean Med Sci. 2006:21(4):678-82.
(4) Joo KJ, Kim BS, Han JH, Kim CJ, Kwon CH, Park HJ. Porcine vesical acelluar matrix graft of tunica albuginea for penile reconstruction. Asian J. of androl. 2006;8(5):543-8.
(5) Seo JT, Lee JS, Oh TH, Joo KJ. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome. BJU International. 2007;99(1):141-6.
(6) Yoon CY, Sung DJ, Lee JH, Kim AR, Oh CW, Je JH, Weon BM, Seol SK, Pyun A, Hwu Y, Margaritondo G, Joo KJ, Yoon DK. Imaging of renal and prostate carcinoma with refractive index radiology. Int J Urol. 2007;14(2):96-103.
(7) Cho HY, Park HS, Lin Z, Kim I, Joo KJ, Cheon J. BCL6 gene mutations in transitional cell carcinomas. J Int Med Res. 2007;35(2):224-30.
(8) Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, Joo KJ, Kim JT, Kim BS, Sung KC. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010:4(3):378-83.
(9) Lee YS, Lee JH, Choi JS, Son CE, Jeon SW, Kim JT, Joo KJ, Cho YS, Jung US. Accessory polar renal artery encounterd in transperitoneal systemic laparoscopic paraaortic lymphadenectomy. Eur J Gynecol Oncol. 2011:32(1):8
(10) Choi H, Kang SH, Yoon DK, Kang SG, Ko HY, Moon DG, Park JY, Joo KJ, Cheon J. Chewing gum has a stimulatory effect on bowel motility in patients after open or robotic radical cystectomy for bladder cancer: a prospective randomized comparative study. Urology. 2011;77(4):884-90.
7-90.
(11) Lee JH, Choi JS, Hong JH, Joo KJ, Kim BY. Does conventional or single port laparoscopically assisted vaginal hysterectomy affect female sexual function? Acta Obstet Gynecol Scand. 2011;90(12):1410-5.
(12) Cho DS, Choi JB, Kim YS, Joo KJ, Kim SH, Kim JC, Kim HW. Heart rate variability in assessment of autonomic dysfunction in patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2011;78(6):1369-72.
(13) Seo HI, Cho YK, Lee WY, Rhee EJ, Sung KC, Kim BS, Son BH, Shin JH, Joo KJ, Hong HP, Chae SW, Jin W. Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease? Diabetes Res Clin Pract. 2012;(95):19-24.
(14) Bae JW, Lee JH, Choi JS, Son CE, Jeon SW, Hong JH, Eom JM, Joo KJ. Laparoscopic lymphadenectomy for gynecologic malignancies: evaluation of the surgical approach and outcomes over a seven year experience. Arch Gynecol Obstet. 2012;285:823-9.
(15) Joo KJ, Sung WS, Park SH, Yang WJ, Kim TH. Comparison of α-blocker monotherapy and α-blocker plus 5-α reductase inhibitor combination therapy based on prostate volume for the treatment of benign prostatic hyperplasia. J Int Med Res. 2012;40(3):899-908.
(16) Cheon CW, Kim BS, Cho YK, Sung KC, Bae JC, Kim TW, Won HS, Joo KJ. Effect of nonalcoholic fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic Korean men. Gut Liver. 2012;6(3):368-73.
(17) Joo KJ, Kwon YW, Myung SC, Kim TH. The effects of smoking and alcohol intake on sperm quality: light and transmission electron microscopic findings. J Int Med Res. 2012;40(6):2327-35.
(18) Lee SH, Park TJ, Bae MH, Choi SH, Cho YS, Joo KJ, Kwon CH, Park HJ. Impact of treatment with statins on prostate-specific antigen and prostate volume in patients with benign prostatic hyperplasia. Korean J Urol. 2013;54(11):750-5.
(19) Kang SG, Ha YR, Ko YH, Kang SH, Joo KJ, Cho HY, Park HS, Kim CH, Kwon SY, Kim JJ, Cheon J, Lee JG. Effect of laminin 332 on motility and invasion in bladder cancer. Kaohsiung J Med Sci. 2013;29(8):422-9.
(20) Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, Kim HJ, Park DI, Park JH, Joo KJ, Kim CJ, Kim YS, Heo WJ, Choi WS. Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. Clin Mol Hepatol. 2013;19(3):258-65.
(21) Joo KJ, Li H, Zhang X, Lerner SP. Therapeutic effect on bladder cancer with a conditionally replicating oncolytic virus derived from type II herpes simplex virus. Bladder Cancer. 2015;1:81-90.
(22) Kim SH, Kim S, Nam BH, Lee SE, Kim CS, Seo IY, Kim TN, Hong SH, Kwon TG, Seo SI, Joo KJ, Song K, Kwak C, Chung J. Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter Study. PLoS One. 2015;10(8):1-15.
(23) Kim HS, Ku JH, Kim SJ, Hong SJ, Hong SH, Kim HS, Kwon TG, Cho JS, Jeon SS, Joo KJ, Ahn HJ, Park HS, Seong DH, Kwon DD, Kim HJ, Lim JS, Lee HL. Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study. Yonsei Med J. 2016;57(4):855-64.
(24) Kim SH, Kim S, Nam BH, Lee SE, Kim CS, Seo IY, Kim TN, Hong SH, Kwon TG, Seo SI, Joo KJ, Song K, Kwak C, Chung J. Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study. Biomed Res Int. 2017;2017:9215930.
(25) Kim S, Chang Y, Sung E, Kang JG, Yun KE, Jung HS, Hyun YY, Lee KB, Joo KJ, Shin H, Ryu S. Association Between Sonographically Diagnosed Nephrolithiasis and Subclinical Coronary Artery Calcification in Adults. Am J Kidney Dis. 2018 Jan;71(1):35-41.
(26) Shin DG, Kim HW, Yoon SJ, Song SH, Kim YH, Lee YG, Joo KJ, Bae JH, Kang TW, Jeong SJ, Woo SH, Yoo ES, Son H, Koo KC, Kim SW. Mirabegron as a treatment for overactive bladder symptoms in men (MIRACLE study): Efficacy and safety results from a multicenter, randomized, double-blind, placebo-controlled, parallel comparison phase IV study. Neurourol Urodyn. 2019 Jan;38(1):295-304.
(27)Kim JK, Kim JJ, Gang TW, Kwon TK, Kim HS, Park SC, Park JS, Park JY, Yoon SJ, Jeon YS, Cho JS, Joo KJ, Hong SH, Byun SS; Korean Urological Oncology Society. The current status of hormone treatment for prostate cancer patients in Korean real-world practice: a multi-institutional observational study. Asian J Androl. 2019 Mar-Apr;21(2):115-120.
(28) Kim S, Chang Y, Yun KE, Jung HS, Kim I, Hyun YY, Lee KB, Joo KJ, Park HJ, Shin H, Ryu S. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes (Lond). 2019 Apr;43(4):852-861.
(29) Kim JK, Cho YS, Park SY, Joo KJ, Min SK, Lee YG, Han JH. Recent surgical treatments for urinary stone disease in a Korean population: National population-based study. Int J Urol. 2019 May;26(5):558-564.
(30) Chang Y, Kim JH, Noh JW, Cho YS, Park HJ, Joo KJ, Ryu S. Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality. Circ Res. 2019 May 10;124(10):1492-1504.
(31) Kim S, Chang Y, Lee YR, Jung HS, Hyun YY, Lee KB, Joo KJ, Yun KE, Shin H, Ryu S. Solitary kidney and risk of chronic kidney disease. Eur J Epidemiol. 2019 Sep;34(9):879-888.
(32) Shim M, Kim JK, Bang WJ, Lee YS, Cho ST, Cho JS, Joo KJ, Hyun JS, Kim BH, Lee JB, Seo YJ, Oh CY. Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study. Investig Clin Urol. 2020 Nov;61(6):600-6.
(33) Kim S, Chang Y, Jung HS, Hyun YY, Lee KB, Joo KJ, Park HJ, Cho YS, Ko H, Sung E, Shin H, Ryu S. Glycemic Status, Insulin Resistance, and the Risk of Nephrolithiasis: A Cohort Study. Am J Kidney Dis. 2020 Nov;76(5):658-668.
(34) Yu YD, Ko YH, Kim JW, Jung SI, Kang SH, Park J, Seo HK, Kim HJ, Jeong BC, Kim TH, Choi SY, Nam JK, Ku JY, Joo KJ, Jang WS, Yoon YE, Yun SJ, Hong SH, Oh JJ. The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up. Front Oncol. 2021 May;11:683190.
(35) Kim MS, Hong HP, Kang KA, Lee YR, Joo KJ, Cho YS, Lee YG. Superselective vesical artery embolization for intractable bladder hemorrhage related to pelvic malignancy. Acta Radiol. 2021 Sep;62(9):1229-1237.

기타

닥터스토리
  • 정보보호관리체계(ISMS) 인증
  • 국제정보보호(ISO27001) 인증
  • 보건복지부
    의료기관 인증병원
  • 생명의학연구윤리 국제인증 획득
  • 美, 하원 표창장
  • 美, 존스홉킨스
    연구협약 체결